ArticleJournal of synchrotron radiation2026
Synchrotron structural biology at SSRL, the beginning and beyond.
Article in Journal of synchrotron radiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- 50th anniversary of the Stanford SSRL synchrotron radiation and protein crystallography initiative.Journal of synchrotron radiation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Synchrotron X-ray structural biology has developed into a worldwide, highly productive enterprise whose capabilities are providing thousands of users annually with the means to make innovative and outstanding scientific discoveries based on biological structure and function, impacting areas of human health, bioenergy and sustainability and many others. This special virtual issue of Journal of Synchrotron Radiation (https://journals.iucr.org/special_issues/2025/ssrlprotein) includes a series of contributed papers from scientists at structural biology synchrotron centers worldwide that describe capabilities, scientific discoveries and future directions. In my article, I will start with a focus on the first macromolecular crystallography studies at SSRL that were published in 1976, followed by developments in anomalous scattering and multi-wavelength phasing. I will then highlight some technology and methodology developments including X-ray detectors and beamline automation, which were key in building robust, sustainable resources at SSRL and other synchrotron radiation facilities for the structural biology user community. I will highlight other related elements including accelerator R&D, consider some of the overarching factors which I believe have been important for the sustained success and growth of this enterprise for 50 years and counting, and highlight some of the indicators of the enormous success of this venture. Throughout I will comment upon some of the new developments and trends that are emerging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.